Logo

miRNA

Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test
Premium

The company is working with three institutions to recruit about 1,200 case-control participants for its validation study, with plans to launch an LDT next year.

Lithuanian Team Developing Droplet-Based Single-Cell Small RNA Sequencing Approach
Premium

The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant.

COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood

The researchers said that more research into these biomarkers could help with patient stratification and therapy selection.

Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia
Premium

The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.

Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19
Premium

The firm's platform, dubbed HNKlear, uses methylation-specific PCR to detect microRNA biomarkers in a patient's blood sample following frontline cancer treatment.

Sep 15, 2020

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

Jul 9, 2020

Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories

May 11, 2020

Genetic Ancestry Linked to Differences in Molecular Features of Cancers

Apr 6, 2020

MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
Premium

Mar 5, 2020

Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer

Dec 18, 2019

ALS Genomic Analysis Highlights Potential MicroRNA Contributor

Nov 21, 2019

DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research

Oct 10, 2019

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

Sep 30, 2019

Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans

Sep 19, 2019

Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia
Premium

Sep 16, 2019

Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA

Aug 29, 2019

Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform

Aug 13, 2019

Interpace Diagnostics Q2 Revenues Climb 14 Percent

Jul 30, 2019

Pan-Cancer Study Uncovers TP53 Mutation Consequences, Related Prognostic Expression Signature

Jul 16, 2019

Arcis Licenses Sample Prep Technology to microRNA Diagnostics Firm Mirnax Biosens

Jul 12, 2019

Avalon GloboCare Using Exosome Isolation Platform to Pursue Oral Cancer Dx, Rx Applications
Premium

Jul 2, 2019

Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding

Jun 17, 2019

Q BioMed Using MicroRNA Biomarkers to Guide Therapy Development in Subset of Autism Patients
Premium

Apr 25, 2019

Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis

Mar 28, 2019

MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer
Premium

Breaking News
The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.